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Background: Flexor tenotomy is a minimally invasive surgical alternative for the treatment of neuropathic diabetic
foot ulcers on the distal end of the toe. The influence of infection on healing and time to heal after flexor
tenotomy is unknown. Flexor tenotomy can also be used as a prophylactic treatment. The effectiveness as a
prophylactic treatment has not been described before.
Methods: A retrospective study was performed with the inclusion of all consecutive flexor tenotomies from one
hospital between January 2005 and December 2011.
Results: From 38 ulcers, 35 healed (92%), with a mean time to heal of 22 ± 26 days. The longest duration for
healing was found for infected ulcers that were penetrating to bone (35 days; p = .042). Cases of prophylactic flexor
tenotomies (n=9) did not result in any ulcer or other complications during follow-up.
Conclusions: The results of this study suggest that flexor tenotomy may be beneficial for neuropathic diabetic foot
ulcers on the distal end of the toe, with a high healing percentage and a short mean time to heal. Infected ulcers
that penetrated to bone took a significantly longer time to heal. Prospective research, to confirm the results of this
retrospective study, should be performed.
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Foot ulcers are a frequently occurring and costly compli-
cation of diabetes, with a yearly incidence around 2%
[1]. Claw and hammer toe deformities frequently de-
velop in people with diabetes, leading to increased pres-
sure on the distal end of the toes [2]. In combination
with neuropathy, this may lead to abundant callus and
the development of ulcers. Conservative treatment of
these ulcers consists of wound care, sharp debridement
and off-loading of the foot by means of shoe adaptations
or casting [3]. A minimally invasive surgical alternative
is flexor tenotomy [4-9].
Four small retrospective studies have recently been
published, describing positive results of flexor tenotomy:
healing rates of 98% to 100% [6-9] after flexor tenotomy,
and mean time to heal ranging from 21 to 56 days [6-9].* Correspondence: jv.netten@zgt.nl
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distribution, and reproduction in any mediumHowever, limited patient information was provided in
those studies, leaving relevant questions unanswered [4].
For example, the influence on healing and time to heal
of preoperative treatment, ulcer duration before flexor
tenotomy, ulcer location or infection at the moment of
flexor tenotomy are all unknown.
Flexor tenotomy can also be performed for prevention
of diabetic foot ulcers, when abundant callus is present
on the distal end of claw and hammer toes. It was
described in one study that in ten cases the flexor tenot-
omy was prophylactic [7]. Unfortunately no further
details were provided regarding effectiveness or compli-
cations during follow-up of this prophylactic surgery [7].
The preventative effects of flexor tenotomy are still
unknown.
The aim of this study was to retrospectively investigate
all consecutive flexor tenotomies in people with neuro-
pathic diabetic foot ulcers on the distal end of the toe, to
report healing and time to heal, and to investigate thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Characteristics of all patients
Patient characteristics (n=33)
Gender M: 17
F: 16
Age (years) Mean±SD 69 ± 12
(range) (41 – 93)
Diabetes type Type 1: 0
Type 2: 33
Neuropathy* Yes: 31
No: 1
Unknown: 1
PAD Yes: 0
No: 33
Foot characteristics (n=47)
Pre-operative Treatment Orthopedic shoe: 14
Cast shoe: 3
Orthosis: 5
Felt: 2
None: 23
Location † Digit 1: 15
Digit 2: 16
Digit 3: 15
Digit 4: 1
Ulcer characteristics (n=38)
Ulcer duration (days) Mean±SD 96 ± 112
(range) (9 – 525)
Ulcer classification ‡ 1A: 14
1B: 6
3B: 18
Note: Values are n, or as indicated; SD = standard deviation; PAD = peripheral
arterial disease, scored as no when foot arteries were palpable by the surgeon;
*: neuropathy was unknown for 1 patient, 1 patient had no neuropathy and
no ulcer (prophylactic flexor tenotomy); †: no difference between left and right
is made. ‡: ulcer classification = University of Texas Wound Classification
system; [10]; Cast shoe = MAnning-Baal-ALmelo cast shoe; [11].
van Netten et al. Journal of Foot and Ankle Research 2013, 6:3 Page 2 of 5
http://www.jfootankleres.com/content/6/1/3influence of preoperative treatment, ulcer duration be-
fore flexor tenotomy, ulcer location, and infection on
healing and time to heal. The second aim was to de-
scribe the outcomes of all consecutive prophylactic
flexor tenotomies in patients with diabetes and claw or
hammer toe deformities.
Methods
Study design
A retrospective cohort study was performed including all
consecutive flexor tenotomies in patients with diabetes
mellitus, performed in one hospital and by one surgeon
between January 2005 and December 2011. For this retro-
spective study, no ethical approval was required. A data-
base containing all surgical procedures in the study period
was scanned for the code representing flexor tenotomy,
after which a list was compiled of all patients who had
undergone a flexor tenotomy.
The medical files of these patients were reviewed for:
(i) patient characteristics (gender, date of birth, diabetes
type, neuropathy assessed with a 10 g Semmes-Weinstein
monofilament, peripheral arterial disease assessed by pal-
pation of pulses in the lower limb followed by hand-held
Doppler evaluation of the flow signals from both foot ar-
teries and measurement of toe pressure, pre-operative
treatment); (ii) ulcer characteristics (duration before flexor
tenotomy, location, presence of infection based on clinical
assessment, depth divided in three groups as superficial,
penetrating to tendon or capsule, penetrating to bone or
joint, University of Texas Wound Classification grade and
stage [10], based on presence of peripheral arterial disease,
infection and depth, date of flexor tenotomy, date of ulcer
healing, complications amputation re-ulceration (develop-
ment of a new ulcer on the same location, after the previ-
ous ulcer was healed) and shifted flexor tenotomy (when a
subsequent flexor tenotomy was performed on the same
foot but on a different toe, the subsequent flexor tenotomy
was listed as shifted flexor tenotomy) during follow-up).
Flexor tenotomy
All flexor tenotomies in the study period were performed
by one surgeon, following a standard protocol [7,8].
Patients underwent outpatient flexor tenotomy under a se-
lective block using 2% lidocaine without adrenaline. The
flexor digitorum longus is placed under tension (‘bow-
stringing’) by positioning the ankle joint in dorsiflexion,
while at the same time positioning the affected toe in
hyperextension. A stab-wound incision (around 3 mm) is
made at the middle of the proximal phalanx, and the ten-
don is cut. All stab wounds are sutured and a pressure
bandage is applied for the first days. The foot remains off-
loaded for 24 hours, after which the patient can weight-
bear again. The patient is examined at 1-week, and
subsequently followed-up at regular intervals.Data analysis
Data were analyzed using SPSS for Windows, version
17.0 (SPSS Inc., Chicago IL, United States of America).
Differences between groups were tested using non-
parametric tests, because of non-normal distribution of
the data.
Results
A total of 47 flexor tenotomies were performed on 33
patients in the study period. Of these flexor tenotomies,
38 were performed because of an ulcer and 9 were
prophylactic. Patient, foot and ulcer characteristics are
described in Tables 1 (group characteristics). For individ-
ual characteristics see the Additional file 1.
Table 3 Relation between time to heal after flexor
tenotomy and ulcer characteristics
Time to heal
(days) (n=35)
Sign
Ulcer duration* Correlation § .170 .329 §
Pre-operative treatment Orthopedic shoes: 15 ± 10 .467 †
Cast: 24 ± 17
Orthosis: 21 ± 3
Felt: 10 ± 4
None 28 ± 34
Ulcer location † Digit 1: 15 ± 6 .483 ζ
Digit 2: 24 ± 17
Digit 3: 27 ± 43
Ulcer classification ‡ 1A: 13 ± 6 .042 ζ
1B: 18 ± 9
3B: 33 ± 37
Note: Values are mean ± standard deviation; Cast = MAnning-Baal-ALmelo cast
shoe;(11) sign. = significance; *: duration unknown for three ulcers; †: no
difference between left and right is made; ‡ : ulcer classification = University of
Texas Wound Classification system;(10) §: Spearman’s ρ; ζ: Kruskal-Wallis test.
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heal of 22 ± 26 days. No relation was found between
healing and ulcer duration before flexor tenotomy, pre-
operative treatment, ulcer location or ulcer classification
(Table 2), although the three ulcers that did not heal were
all infected and penetrated to bone (Table 2). A significant
relation was found between time to heal and ulcer classifi-
cation, with the shortest time to heal in superficial ulcers
without infection, and the longest time to heal seen
in infected ulcers penetrating to bone (13 vs. 35 days;
p = .042; Table 3). No relation was found between time to
heal and ulcer duration before flexor tenotomy, pre-
operative treatment or ulcer location (Table 3).
Mean follow-up time was 23 ± 11 months (range:
11 – 60 months). Complications of amputation (n=3) and
re-ulceration (n=7) were only found in infected ulcers
penetrating to bone at the moment of flexor tenotomy
(see Additional file 1). Toe amputation was performed for
all three cases with an ulcer that did not heal, after 29, 68,
and 134 days. Reason for amputation was spreading of the
infection. All amputation wounds healed. Re-ulceration
occurred on the plantar side of the toe (n=6), and on the
dorsal side of the toe (n=1). The latter was the result from
dorsiflexion of the metatarsophalangeal joint caused by
the extensor digitorum longus muscle, even though there
was no active muscle contraction. Treatment after re-
ulceration consisted of antibiotics and shoe adaptations.
Eight tenotomies were listed as shifted, meaning they were
performed on the same foot after the first flexor tenotomy
(see Additional file 1).Table 2 Relation between healing after flexor tenotomy
and ulcer characteristics
Not healed
(n=3)
Healed
(n=35)
p-value
Ulcer
duration* (days)
Mean±SD 131±175 93±108 .828 ‡
(range) (23–333) (9–525)
Pre-operative
treatment
Orthopedic shoe: 1 9 .711 §
Cast: 1 2
Orthosis: 0 4
Felt: 0 2
None 1 18
Ulcer location † Digit 1: 2 10 .178 §
Digit 2: 1 14
Digit 3: 0 11
Ulcer
classification ‡
1A: 0 14 .259 §
1B: 0 6
3B: 3 15
Note: Values are n or as indicated; OS = orthopaedic shoes; Cast shoe =
MAnning-Baal-ALmelo cast shoe; [11]; sign. = significance; *: duration
unknown for three healed ulcers; †: no difference between left and right is
made; ‡: ulcer classification = University of Texas Wound Classification system;
[10]; ‡: Mann–Whitney U test; §: Fisher’s Exact test.Nine flexor tenotomies were prophylactic, performed
when abundant callus was present on the distal end of
the toe (see Additional file 1). None of these toes devel-
oped an ulcer or any other complication during follow-
up (see Additional file 1).
Discussion
Flexor tenotomy is a minimally invasive surgical proced-
ure for off-loading claw and hammer toe deformities. In
this retrospective study, previously reported findings that
diabetic foot ulcers on the distal end of the toe heal
quickly after flexor tenotomy were replicated [6-9]. The
rate of non-healing ulcers found in the population of
this study is slightly higher (9%) than seen in recently
published retrospective studies (0% - 2% [6-9]). All three
ulcers that did not heal were infected and penetrated to
bone at the moment of flexor tenotomy. Re-ulceration
was a complication found in seven patients, which is
slightly higher than previous studies where this was
described [6,8]. As with amputation, re-ulceration oc-
curred only in toes that were infected and penetrating to
bone at the moment of flexor tenotomy. With scarce in-
formation on infection available from previous studies,
options to reliably compare these findings are unfortu-
nately limited. Infected ulcers penetrating to bone are
not a contra-indication for performing flexor tenotomy,
as the majority of these ulcers healed and approximately
half of them without complications. However, with am-
putation and re-ulceration only found in this group, the
timing of the flexor tenotomy should be investigated in
respect to performing the procedure earlier or later (be-
fore an ulcer becomes infected and penetrating to bone
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ing to bone is no longer possible), or if a different treat-
ment (e.g. off-loading by means of cast or shoe
adaptations) is preferred.
A complication that has been described before is shift-
ing of the foot problem [6]. After successful flexor tenot-
omy, the next toe may develop an ulcer due to the
increased pressure under that toe. The change to the
structure and therefore function of the diabetic foot has
implications for a shift in plantar pressures and other
forces affecting the foot, sometimes resulting in a new
ulcer on the next toe. Shifted flexor tenotomy is then
one of the first treatment options to consider. With
eight shifted flexor tenotomies found in our population,
this is not a rare complication. Frequent follow-up visits
are essential to timely detect these ulcers, or the abun-
dant callus which is a pre-sign of these ulcers. A compli-
cation after flexor tenotomy that has not been described
before was dorsiflexion of the metatarsophalangeal joint.
This may be caused by the extensor digitorum longus
muscle, without active muscle contraction, or by the in-
advertent release of the flexor brevis muscle. This was
found in one patient, one month after the flexor tenot-
omy. There was inadequate space in the toe-box of the
shoe due to the altered toe position, and consequently
an ulcer developed on the dorsal side of the toe. Fre-
quent follow-up visits and timely made shoe adaptations
can prevent ulceration due to this complication.
Prophylactic flexor tenotomies have only been
described once, yet without describing the effectiveness
of the prophylactic intervention [7]. In this study,
prophylactic flexor tenotomy was successful in the pre-
vention of ulcer development during long-term follow-
up. This suggests that flexor tenotomy may hold promise
as a measure for prevention and might be considered, if
possible, in an early stage of treatment, before an ulcer
can develop. It should be noted that our sample was lim-
ited to nine people only, so more research is needed be-
fore we can draw definitive conclusions.
The retrospective nature of this study presents an im-
portant limitation. Although prospective studies are pre-
ferred [4], this retrospective design was chosen to
investigate the relation between ulcer duration, pre-
operative treatment, ulcer location, or infection on heal-
ing and time to heal after flexor tenotomy. The findings,
especially concerning the influence of infection and
penetrating to bone at the moment of flexor tenotomy,
are relevant and useful additions when setting up pro-
spective trials. The effect of flexor tenotomy should be
compared with conservative non-surgical treatment
options such as off-loading by means of casting or shoe
adaptations, and also compared with open surgical pro-
cedures such as resection arthroplasty and toe amputa-
tion in future research. The influence of infection onnegative outcomes seen in this study cohort should be
considered further to determine optimal timing for sur-
gical procedures in the diabetic foot.
Conclusions
The results of this study suggest that flexor tenotomy
may be beneficial for neuropathic diabetic foot ulcers on
the distal end of the toe, with a high healing percentage
and a short mean time to heal. Infection and penetrating
to bone should not be considered contra-indications.
However, these cases may experience delayed healing
times and an increased risk of complications during fol-
low-up. Prophylactic flexor tenotomy may hold promise
as a measure for prevention of ulceration on the distal
end of the toe. Prospective research, to confirm the
results of this retrospective study and to compare flexor
tenotomy with other forms of treatment, should be per-
formed before definitive conclusions can be drawn.
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